This landmark study reported on outcomes after surgical repair of RD in patients with pseudophakia
In this video, Duy Do, PhD explains what the data show and what it means for patients at elevated cardiovascular risk
Lifestyle interventions like regular exercise, stress reduction through mindfulness, and a balanced diet rich in aphrodisiac nutrients (e.g., zinc, omega-3s) can help by boosting blood flow and hormone balance, but after 40, these may not suffice as baseline melanocortin efficiency drops by 30-50% in some women, leading to persistent HSDD.[1][2] This is where PT-141 excels: as an MC4R agonist, it directly reactivates arousal pathways to mimic natural desire, enhancing libido and response without daily commitmentclinical trials show 51% of women experienced improved desire versus 21% on placebo.[1] Preclinical and human studies demonstrate it reverses HSDD by increasing dopamine in the hypothalamus, offering a targeted boost for those with hormonal or neurological barriers.[2] Pairing it with HRT can sustain these effects longer, as estrogen replenishes vaginal tissues that PT-141 stimulates for better lubrication and comfortscientific evidence shows this combination addresses both neurological and hormonal roots, yielding better outcomes than either alone, with up to 60% reporting reduced pain and heightened satisfaction.[3][9] For a scientific lens, HRT modulates estrogen receptors to improve GSM, while PT-141's cAMP pathway amplifies neural signaling, creating synergy that enhances overall function
Wang LW, Wang Z, Ersing I, et al
It also marks an important inflection point for our development pipeline and longterm value creation
Our aim was to use MSD technology to produce a customized multiplex assay dedicated to GH detection for doping controls
